Differentiated approaches to the development of prolonged treatment regimens for patients with endometriosis in the postoperative period

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective: To analyze the characteristics of the management of patients with endometriosis who underwent surgery in the gynecological department over two years in order to develop personalized therapy for endometriosis; to analyze the preferable duration of use of dydrogesterone as effective anti-relapse therapy for endometriosis.

Materials and methods: The retrospective study included 292 patients of reproductive age (16-49 years old) diagnosed with endometriosis. The patients underwent laparoscopic treatment for endometriosis at the Clinic of Obstetrics and Gynecology of Pavlov First Saint Petersburg State Medical University, Russia from 2021 to 2023. The preferable duration of treatment was discussed on the basis of retrospective analysis and clinical case series.

Results: Endometriomas were found in 176/292 (60.3%) patients and were significantly more frequent in groups with stage III and IV endometriosis (p<0.0001). Peritoneal endometriosis was detected more often intraoperatively in patients with stage I and II endometriosis (p=0.000002). All patients received long-term hormone-modulating therapy when there were indications and no contraindications. Recurrence of endometriosis was noted in women who received combined oral contraceptives and dienogest as they had poor tolerance to therapy.

Conclusion: Surgical treatment for endometriosis should be performed only when indicated and during intraoperative staging of the disease. Taking into account the risks of complications and decreased quality of life in case of repeated surgical intervention for recurrent endometriosis and possible reproductive plans of the patient, further treatment in the form of personalized drug therapy is advisable. Effective and safe therapy of endometriosis with dydrogesterone can be recommended to the patient for a long time, more than 48 months, which allows to minimize the risk of recurrence of the disease.

Full Text

Restricted Access

About the authors

Vitaly F. Bezhenar

Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia

Author for correspondence.
Email: bez-vitaly@yandex.ru
ORCID iD: 0000-0002-7807-4929

Dr. Med. Sci., Professor, Head of the Departments of Obstetrics, Gynecology and Neonatology/Reproductology, Head of the Clinic of Obstetrics and Gynecology; Main Supernumerary Specialist Obstetrician-Gynecologist of the Health Committee of St. Petersburg

Russian Federation, St. Petersburg

Natalya S. Kuzmina

Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia

Email: dok.kuzmina@gmail.com
ORCID iD: 0000-0002-8404-1859

PhD, Head of the Oncology Department No. 7, Teaching Assistant at the Department of Obstetrics, Gynecology and Neonatology

Russian Federation, St. Petersburg

Sviatoslav Yu. Kruglov

Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia

Email: skruglov89@mai.ru
ORCID iD: 0000-0001-7399-3398

PhD, Teaching Assistant at the Department of Obstetrics Gynecology and Reproductology

Russian Federation, St. Petersburg

Ana G. Gramatikova

Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia

Email: frau.gramatikova@yandex.ru
ORCID iD: 0000-0001-7463-1831

PhD student at the Department of Obstetrics, Gynecology and Reproductology

Russian Federation, St. Petersburg

Vera A. Izorkina

Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia

Email: izorkina.vera@yandex.ru
ORCID iD: 0000-0002-1316-5280

Teaching Аssistant at the Department of Obstetrics, Gynecology and Reproductology

Russian Federation, St. Petersburg

Irina V. Medvedeva

Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia

Email: iriska18.05@mail.ru
ORCID iD: 0000-0002-5625-7855

Obstetrician-Gynecologist at the Oncology Department No. 7

Russian Federation, St. Petersburg

Aleksandr D. Demidov

Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia

Email: alexander.demidov.1997@gmail.com
ORCID iD: 0009-0006-7618-7272

PhD student at Department the Obstetrics, Gynecology and Reproductology

Russian Federation, St. Petersburg

Daria S. Strukova

Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia

Email: dashastr97@inbox.ru
ORCID iD: 0009-0008-1597-0946

PhD student at the Department the Obstetrics, Gynecology and Reproductology

Russian Federation, St. Petersburg

Dariia V. Fedosova

Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia

Email: fedosova.dariya@yandex.ru
ORCID iD: 0000-0003-1030-6110

PhD student at the Department the Obstetrics, Gynecology and Reproductology

Russian Federation, St. Petersburg

Ilarion A. Barnash

Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia

Email: Barnash.LA@yandex.com
ORCID iD: 0009-0006-9177-7166

PhD student at the Department the Obstetrics, Gynecology and Reproductology

Russian Federation, St. Petersburg

References

  1. Министерство здравоохранения Российской Федерации. Клинические рекомендации. Эндометриоз. М.; 2020. [Ministry of Health of the Russian Federation. Clinical guidelines. Endometriosis. Moscow; 2020. (in Russian)].
  2. Тихомиров А.Л. Триггеры и профилактика эндометриоза. Трудный пациент. 2019; 17(8-9): 13-9. [Tikhomirov A.L. Triggers and prevention of endometriosis. Difficult patient. 2019; 17(8-9): 13-9. (in Russian)]. https://dx.doi.org/10.24411/2074-1995-2019-10056.
  3. Баскаков В.П., Цвелев Ю.В., Кира Е.Ф. Эндометриоидная болезнь. СПб.: Издательство Н-Л; 2002. 452 с. [Baskakov V.P., Tsvelev Yu.V., Kira E.F. Endometrioid disease. St. Petersburg: Publishing House N-L; 2002. 452 p. (in Russian)].
  4. Дубровина С.О., Беженарь В.Ф., ред. Эндометриоз. Патогенез, диагностика, лечение. М.: ГЭОТАР-Медиа; 2020. 352 с. [Dubrovina S.O., Bezhenar V.F., ed. Endometriosis. Pathogenesis, diagnosis, treatment. Moscow: GEOTAR-Media; 2020. 352 p. (in Russian)]. https://dx.doi.org/10.33029/ 9704-5802-0-END-2020-1-352.
  5. ESHRE Endometriosis Guideline Development Group. Endometriosis. Guideline of European Society of Human Reproduction and Embryology. 2022. 192 p. Available at: https://www.eshre.eu/Guidelines-and-Legal/Guidelines/Endometriosis-guideline.
  6. Fauconnier A., Chapron C. Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications. Hum. Reprod. Update. 2005; 11(6): 595-606. https://dx.doi.org/10.1093/humupd/dmi029.
  7. Schliep K.C., Mumford S.L., Peterson C.M., Chen Z., Johnstone E.B., Sharp H.T. et al. Pain typology and incident endometriosis. Hum. Reprod. 2015; 30(10): 2427-38. https://dx.doi.org/10.1093/humrep/dev147.
  8. Burghaus S., Hildebrandt T., Fahlbusch Ch., Heusinger K., Antoniadis S., Lermann J. Standards used by a clinical and scientific endometriosis center for the diagnosis and therapy of patients with endometriosis. Geburtshilfe Frauenheilkd. 2019; 79(5): 487-97. https://dx.doi.org/10.1055/a-0813-4411.
  9. Cardoso J.V., Perini J.A., Machado D.E., Pinto R., Medeiros R. Systematic review of genome-wide association studies on susceptibility to endometriosis. Eur. J. Obstet. Gynecol. Reprod. Biol. 2020; 255: 74-82. https://dx.doi.org/10.1016/ j.ejogrb.2020.10.017.
  10. Адамян Л.В., Андреева Е.Н., Аполихина И.А., Беженарь В.Ф., Геворкян М.А., Гус А.И., Демидов В.Н., Калинина Е.А., Леваков С.А., Марченко Л.А., Попов А.А., Сонова М.М., Хашукоева А.З., Чернуха Г.Е., Яроцкая Е.Л. Эндометриоз: диагностика, лечение и реабилитация. Федеральные клинические рекомендации по ведению больных. М.; 2013. 86 с. [Adamyan L.V., Andreeva E.N., Apolikhina I.A., Bezhenar V.F., Gevorkyan M.A., Gus A.I., Demidov V.N., Kalinina E.A., Levakov S.A., Marchenko L.A., Popov A.A., Sonova M.M., Khashukoeva A.Z., Chernukha G.E., Yarotskaya E.L. Endometriosis: diagnosis, treatment and rehabilitation. Federal clinical guidelines for patient management. Moscow; 2013. 86 p. (in Russian)].
  11. Кузьмина Н.С., Беженарь В.Ф., Калугина А.С. Эндометриоз и бесплодие. Операция или вспомогательные репродуктивные технологии? Архив акушерства и гинекологии им. В.Ф. Снегирева. 2018; 1(5): 31-6. [Kuzmina N.S., Bezhenar V.F., Kalugina A.S. Endometriosis and infertility. Operation and assisted reproductive technologies? V.F. Snegirev Archives of Obstetrics and Gynecology. Russian journal. 2018; 1(5): 31-6. (in Russian)]. https://dx.doi.org/10.18821/2313-8726-2018-5-1-31-36.
  12. Gałczyński K., Jóźwik M., Lewkowicz D., Semczuk-Sikora A., Semczuk A. Ovarian endometrioma – a possible finding in adolescent girls and young women: a mini-review. J. Ovarian Res. 2019; 12(1): 104. https://dx.doi.org/10.1186/s13048-019-0582-5.
  13. Хамошина М.Б., Оразов М.Р., Абитова М.З., Волкова С.В., Арютин Д.Г., Алеев И.А., Байрамова А.А. Бесплодие, ассоциированное с эндометриозом яичников: современный взгляд на проблему. Вопросы гинекологии, акушерства и перинатологии. 2021; 20(1): 98–104. [Khamoshina M.B., Orazov M.R., Abitova M.Z., Volkova S.V., Aryutin D.G., Aleev I.A., Bayramova A.A. Infertility associated with ovarian endometriosis: a modern view to the problem. Gynecology, Obstetrics and Perinatology. 2021; 20(1): 98-104. (in Russian)]. https://dx.doi.org/10.20953/ 1726-1678-2021-1-98-104.
  14. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil. Steril. 1997; 67(5): 817-21. https:// dx.doi.org/10.1016/s0015-0282(97)81391-x.
  15. Сухих Г.Т., Серов В.Н., Адамян Л.В., Баранов И.И., Беженарь В.Ф., Габидуллина Р.И., Дубровина С.О., Козаченко А.В., Подзолкова Н.М., Сметник А.А., Тапильская Н.И., Уварова Е.В., Ших Е.В., Ярмолинская М.И. Алгоритмы ведения пациенток с эндометриозом: согласованная позиция экспертов Российского общества акушеров-гинекологов. Акушерство и гинекология. 2023; 5: 159-76. [Sukhikh G.T., Serov V.N., Adamyan L.V., Baranov I.I., Bezhenar V.F., Gabidullina R.I., Dubrovina S.O., Kozachenko A.V., Podzolkova N.M., Smetnik A.A., Tapilskaya N.I., Uvarova E.V., Shikh E.V., Yarmolinskaya M.I. Algorithms for the management of patients with endometriosis: an agreed position of experts from the Russian Society of Obstetricians and Gynecologists. Obstetrics and Gynecology. 2023; (5): 159-76. (in Russian)]. https://dx.doi.org/10.18565/ aig.2023.132.
  16. Velebil P., Xia Z., Wilcox L., Peterson H. Rate of hospitalization for gynecologic disorders among reproductive-age women in the United States. Obstet. Gynecol. 1995; 86(5): 764-9. https://dx.doi.org/10.1016/0029-7844(95)00252-M.
  17. Missmer S.A., Hankinson S.E., Spiegelman D., Barbieri R.L., Marshall L.M., Hunter D.J. Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors. Am. J. Epidemiol. 2004; 160(8): 784-96. https://dx.doi.org/10.1093/aje/kwh275.
  18. Houston D.E., Noller K.L., Melton L.J. 3rd, Selwyn B.J. The epidemiology of pelvic endometriosis. Clin Obstet Gynecol. 1988; 31(4): 787-800. https:// dx.doi.org/10.1097/00003081-198812000-00005.
  19. Sangi-Haghpeykar H., Poindexter A.N. 3rd. Epidemiology of endometriosis among parous women. Obstet Gynecol. 1995; 85(6): 983-92. https:// dx.doi.org/10.1016/0029-7844(95)00074-2.
  20. Schliep K.C., Mumford S.L., Peterson C.M., Chen Z., Johnstone E.B., Sharp H.T. et al. Pain typology and incident endometriosis. Hum. Reprod. 2015; 30(10): 2427-38. https://dx.doi.org/10.1093/humrep/ dev147.
  21. Apostolopoulos N.V., Alexandraki K.I., Gorry A., Coker A. Association between chronic pelvic pain symptoms and the presence of endometriosis. Arch. Gynecol. Obstet. 2016; 293(2): 439-45. https://dx.doi.org/10.1007/ s00404-015-3855-2.
  22. Bulun S.E., Yilmaz B.D., Sison C., Miyazaki K., Bernardi L., Liu S. et al. Endometriosis. Endocr. Rev. 2019; 40(4): 1048-79. https://dx.doi.org/10.1210/er.2018-00242.
  23. Benaglia L., Somigliana E., Vighi V., Ragni G., Vercellini P., Fedele L. Rate of severe ovarian damage following surgery for endometriomas. Hum. Reprod. 2010; 25(3): 678-82. https://dx.doi.org/10.1093/humrep/dep464.
  24. Lee D., Kim S.K., Lee J.R., Jee B.C. Management of endometriosis-related infertility: Considerations and treatment options. Clin. Exp. Reprod. Med. 2020; 47(1): 1-11. https://dx.doi.org/10.5653/cerm.2019.02971.
  25. Kim J.Y., Jee B.C., Suh C.S., Kim S.H. Preoperative serum anti-Mullerian hormone level in women with ovarian endometrioma and mature cystic teratoma. Yonsei Med. J. 2013; 54(4): 921-6. doi: 10.3349/ymj.2013.54.4.921.
  26. Беженарь В.Ф., Кузьмина Н.С., Калугина А.С., Круглов С.Ю., Граматикова А.Г., Габдулла А.Б., Кульнева Е.С. Влияние хирургического лечения эндометриом яичников на состояние овариального резерва у пациенток с бесплодием. Эффективная фармакотерапия. 2022; 18(24): 6-11. [Bezhenar V.F., Kuzmina N.S., Kalugina A.S., Kruglov S.Yu., Gramatikova A.G., Gabdulla A.B., Kulneva Ye.S. The effect of surgical treatment of ovarian endometriomas on the state of ovarian reserve in patients with infertility. Efficient Pharmacotherapy. 2022; 18(24): 6-11. (in Russian)]. https://dx.doi.org/10.33978/2307-3586-2022-18-24-6-11.
  27. Skorupskaite K., Hardy M., Bhandari H., Yasmin E., Saab W., Seshadri S. Evidence based management of patients with endometriosis undergoing assisted conception: British fertility society policy and practice recommendations. Hum Fertil (Camb). 2024; 27(1): 2288634. https://dx.doi.org/10.1080/ 14647273.2023.2288634.
  28. Беженарь В.Ф., Круглов С.Ю., Кузьмина Н.С., Крылова Ю.С., Сергиенко А.С., Абилбекова А.К., Жемчужина Т.Ю. Целесообразность длительной гормональной терапии эндометриоза после хирургического лечения. Акушерство и гинекология. 2021; 4: 134-42. [Bezhenar V.F., Kruglov S.Yu., Kuzmina N.S., Krylova Yu.S., Sergienko A.S., Abilbekova A.K., Zhemchuzhina T.Yu. Effectiveness of long-term hormone therapy for endometriosis after surgical treatment. Obstetrics and Gynecology. 2021; (4): 134-42. (in Russian)]. https://dx.doi.org/10.18565/aig.2021.4.134-142.
  29. Адамян Л.В., Серов В.Н., Сухих Г.Т., Филиппов О.С. Клинические рекомендации. Акушерство и гинекология. Эндометриоз: диагностика, лечение и реабилитация. Проблемы репродукции. 2017; 23(S3): 516-60. [Adamyan L.V., Serov V.N., Sukhikh G.T., Filippov O.S. Clinical guidelines. Obstetrics and gynecology. Endometriosis: diagnosis, treatment and rehabilitation. Russian Journal of Human Reproduction. 2017; 23(S3): 516-60. (in Russian)].
  30. Беженарь В.Ф., Ярмолинская М.И., Байлюк Е.Н., Цыпурдеева А.А., Цицкарава Д.З., Моругина Е.В., Постникова Т.Б., Орехова Е.К. Сравнение эффективности различных схем гормономодулирующей терапии после хирургического лечения наружного генитального эндометриоза. Проблемы репродукции. 2015; 21(4): 89-98. [Bezhenar' V.F., Iarmolinskaia M.I., Baĭliuk E.N., Tsypurdeeva A.A., Tsitskarava D.Z., Morugina E.V., Postnikova T.B., Orekhova E.K. The comparison of the efficacy of different regimens of postoperative hormonal therapy in infertile women with endometriosis. Russian Journal of Human Reproduction. 2015; 21(4): 89-98. (in Russian)]. https://dx.doi.org/10.17116/repro201521489-98.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Laparoscopic picture of bilateral endometrioid ovarian cysts in patient A.

Download (202KB)
3. Fig. 2. MRI image of endometrioid ovarian cysts in patient K.

Download (137KB)

Copyright (c) 2024 Bionika Media